Laboratoire de Bioimagerie et Pathologies


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2011

2 février 2015

A. ABUSNINA, M. ALHOSIN, T. KERAVIS, C.D. MULLER, G. FUHRMANN, C. BRONNER & C. LUGNIER. Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis. Cell. Signal. 23, 152-160, 2011 – IF 4.23

A. ABUSNINA, T. KERAVIS, I. YOUGBARÉ, C. BRONNER & C. LUGNIER. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol. Nutr. Food Res. 55, 1677-1689, 2011 – IF 5.10

M. ALHOSIN, T. SHARIF, M. MOUSLI, N. ETIENNE-SELLOUM, G. FUHRMANN, V.B. SCHINI-KERTH & C. BRONNER. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J. Exp. Clin. Cancer Res. 30, 41, 2011 – IF 3.10

D.A. ANDERSSON, C. GENTRY, L. ALENMYR, D. KILLANDER, S.E. LEWIS, A. ANDERSSON, B. BUCHER, J.L. GALZI, O. STERNER, S. BEVAN, E.D. HÖGESTÄTT & P. ZYGMUNT. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol. Nat. Commun. 2, 551, 2011 – IF 11.02

F.J.J. BIHEL, H. JUSTINIANO, M. SCHMITT, M. HELLAL, M.A. IBRAHIM, C. LUGNIER & J.J. BOURGUIGNON. New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam. Bioorg. Med. Chem. Lett. 21, 6567-6572, 2011 – IF 2.45

N. CHOUCAIR-JAAFAR, V. LAPORTE, R. LEVY, P. POINDRON, Y. LOMBARD & J.P. GIES. Complement receptor 3 (CD11b/CD18) is implicated in the elimination of beta-amyloid peptides. Fundam. Clin. Pharmacol. 25, 115-122, 2011 – IF 2.15

T.B. DERAMAUDT, D. DUJARDIN, A. HAMADI, F. NOULET, K. KOLLI, J. de MEY, K. TAKEDA & P. RONDE. FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion. Mol. Biol. Cell 22, 964-975, 2011 – IF 5.15

S. LECAT, M. OUEDRAOGO, T. CHERRIER, F. NOULET, P. RONDE, N. GLASSER, J.L. GALZI, Y. MELY, K. TAKEDA & B. BUCHER. Contribution of a tyrosine-based motif to cellular trafficking of wild-type and truncated NPY Y1 receptors. Cell. Signal. 23, 228-238, 2011 – IF 4.23

C. LUGNIER. PDE inhibitors : a new approach to treat metabolic syndrome ? Curr. Opin. Pharmacol. 11, 698-706, 2011 – IF 5.75

E. SICK, A. BOUKHARI, T. DERAMAUDT, P. RONDE, B. BUCHER, P. ANDRE, J.P. GIES & K. TAKEDA. Activation of CD47 receptors causes proliferation of human astrocytoma but not normal astrocytes via an Akt-dependent pathway. Glia 59, 308-319, 2011 – IF 5.37

K. VIVOT, A. LANGLOIS, N. JEANDIDIER, W. BIETIGER, M. PINGET, J.P. GIES & S. SIGRIST. Instant blood-mediated inflammatory reaction during islet transplantation : the role of toll-like receptors signalling pathways. Transplant. Proc. 43, 3192-3194, 2011 – IF 1.02

E. WOLDT, R.L. MATZ, J. TERRAND, M. MLIH, C. GRACIA, S. FOPPOLO, S. MARTIN, V. BRUBAN, J. JI, E. VELOT, J. HERZ & P. BOUCHER. Differential signaling by adaptor molecules LRP1 and ShcA regulates adipogenesis by the insulin-like growth factor-1 receptor. J. Biol. Chem. 286, 16775-16782, 2011 – IF 4.86

I. YOUGBARÉ, C. MORIN, F.Y. SENOUVO, C. SIROIS, R. ALBADINE, C. LUGNIER & E. ROUSSEAU. NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues. Am. J. Physiol.-Lung Cell. Mol. Physiol. 301, L441-L450, 2011 – IF 4.34